Minute Insight: Nutromics Raises $14m As Dexcom Signals Move Into Wider Sensing Capabilities
Nutromics is working on a portfolio of aptamer-based sensors capable of measuring a wide range of analytes found in interstitial fluid.
You may also be interested in...
The company has enrolled the first patient in the second human trial of its implantable metabolite monitoring system, which it expects could change the game for blood glucose measurement.
The company announced that it is developing a new biowearable device that will continuously monitor both glucose and ketone levels with one sensor.
An interactive look at recent executive-level company changes and promotions in the biopharma, medical device and diagnostics industries.